Liability, Licensing and the Flu Vacine Market: Making Decisions Today to Prevent a Crisis Tomorrow
November 16, 2004
Statements of Committee Members
Witness Testimony
Lester Crawford, Acting Commissioner, Food and Drug Administration, Washington, DC
Mitchell Cohen, Director, Coordinating Center for Infectious Diseases, Center for Disease Control and Prevention, Atlanta, Georgia
Peter Paradiso, Vice President for New Business & Scientific Affairs, Wyeth Pharmaceuticals, Collegeville, Pennsylvania
Frank Sloan, Center for Health Policy, Law and Management, Terry Sanford Institute of Public Policy, Duke University, Durham, North Carolina
Hearing Publications
